The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
According to AbbVie's latest financial reports the company's current EPS (TTM) is 3,32 €. In 2022 the company made an earnings per share (EPS) of 6,01 € an increase over its 2021 EPS that were of 5,85 €.